Cabot Corporation (NYSE:CBT) Given Average Rating of “Hold” by Brokerages

Shares of Cabot Corporation (NYSE:CBT) have been assigned an average rating of “Hold” from the seven research firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $89.00.

CBT has been the subject of a number of research reports. JPMorgan Chase & Co. increased their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. UBS Group cut their price objective on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a report on Wednesday, August 5th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Mizuho increased their price objective on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. Finally, Truist Financial set a $100.00 target price on Cabot in a research note on Wednesday, August 5th.

Cabot Stock Performance

Shares of CBT opened at $86.58 on Thursday. The company has a market capitalization of $4.47 billion, a PE ratio of 24.39, a price-to-earnings-growth ratio of 11.35 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. Cabot has a one year low of $58.33 and a one year high of $94.53. The company’s fifty day moving average price is $87.93 and its 200 day moving average price is $80.25.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The company had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. During the same period in the prior year, the company earned $1.90 earnings per share. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts expect that Cabot will post 6.33 earnings per share for the current year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. Cabot’s dividend payout ratio is 53.24%.

Insider Buying and Selling at Cabot

In related news, CEO Sean D. Keohane sold 91,923 shares of the stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,921,218.94. This trade represents a 18.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.08% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Torren Management LLC acquired a new position in shares of Cabot in the 4th quarter valued at approximately $26,000. Rothschild Investment LLC lifted its position in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after buying an additional 259 shares in the last quarter. Northwestern Mutual Wealth Management Co. acquired a new position in Cabot during the second quarter valued at approximately $33,000. Global Retirement Partners LLC grew its stake in shares of Cabot by 1,606.9% in the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares in the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.